T Cells Promote Distinct Transcriptional Programs of Cutaneous Inflammatory Disease in Keratinocytes and Dermal Fibroblasts

    Hannah A. DeBerg, Mitch Fahning, Suraj R. Varkhande, James D. Schlenker, William P. Schmitt, Aayush Gupta, Archana Singh, Iris K. Gratz, Jeffrey Carlin, Daniel Campbell, Peter A. Morawski
    TLDR T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.
    The study explores how T cells influence gene expression in keratinocytes and dermal fibroblasts, affecting cutaneous inflammatory diseases like psoriasis and scleroderma. It finds that CD4+CLA+ T-cell populations induce specific gene expressions, with T helper 17 cells affecting keratinocyte genes linked to psoriasis, which can be normalized with anti–IL-17 therapy. A transcriptional module from CD103+ skin-resident T cells is present in healthy skin but reduced in psoriasis and scleroderma. The research underscores the significance of understanding T-cell subsets and their gene expressions to distinguish between inflamed and healthy skin and to assess patient responses to biologic therapies.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results